With growth in percutaneous fixes for the valve, surgeons at STS 2025 called for innovation, team-based care, and more data.

Background Mitral valve repair (MVr) is the gold standard treatment for degenerative mitral regurgitation, yet there is ...

We came across a bullish thesis on Edwards Lifesciences Corporation (EW) on Substack by Natan. In this article, we will ...

A handful of years ago, something was wrong with Mike Wortman’s health. It was a mystery to him and his doctors.

Taiwanese actress Barbie Hsu reportedly missed two critical chances to be saved, including one when she refused ...

Stifel Nicolaus upgraded shares of Edwards Lifesciences (NYSE:EW – Free Report) from a hold rating to a buy rating in a report published on Thursday morning, Ratings reports. The firm currently has ...

Edwards Lifesciences Co. (NYSE:EW – Get Free Report) has been given a consensus rating of “Hold” by the twenty-six ratings firms that are presently covering the stock, Marketbeat Ratings reports. One ...

A 78-year-old patient with severe mitral regurgitation has successfully undergone the MitraClip procedure, marking a ...